CYPHERPUNK TECHNOLOGIES INC. Stock Issued During Period, Shares, New Issues
CYPHERPUNK TECHNOLOGIES INC. (CYPH) had Stock Issued During Period, Shares, New Issues of 7.56 million shares as of 2019-02-05, per its 10-K filed 2021-03-12.
Discontinued › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesNewIssues · last filed 2021-03-12
- 2019-02-05: Stock Issued During Period, Shares, New Issues 7.56M shares.
- 2018-03-27: Stock Issued During Period, Shares, New Issues 2.15M shares.
| Period end | Stock Issued During Period, Shares, New Issues |
|---|---|
| 2019-02-05 | 7.56M shares 10-K · filed 2021-03-12 |
| 2018-03-27 | 2.15M shares 10-K · filed 2020-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |